Pinpoint Patient Recruiting, a market research recruitment company, is looking to speak with patients, and their caregivers, who have been diagnosed with Acute Myeloid Leukemia (AML) to participate in an online activity and telephone interview about their experiences.
If you (or your loved one) have been diagnosed with AML in the last 5 years and have taken Venclexta, Vidaza or Dacogen as a first line of treatment, you may be eligible to participate. Participants must be residents of the US and at least 45 years old. Those who qualify and participate in the study will receive up to $180 as a thank you. All information and responses will remain confidential.
Interested?
To see if you qualify for the study or to get more information, please visit http://www.pinpointpatientrecruiting.com/aml-2022 or contact Kathryn at kathryn@pinpointpatientrecruiting.com.
.
